According to clinical trial data presented at the American Association of Cancer Research (AACR) Annual Meeting in Chicago, a drug previously approved for the maintenance treatment of other recurrent cancers has reduced the risk of death or progression in patients with mesothelioma by 27%. The drug, Zejula (niraparib), is part of the NERO study being
The post Researchers Report Promising Results from NERO Mesothelioma Study appeared first on Mesothelioma.net.
from Mesothelioma.net https://ift.tt/8wnjpBM
via IFTTT
Researchers Report Promising Results from NERO Mesothelioma Study
![Researchers Report Promising Results from NERO Mesothelioma Study]()
Reviewed by Unknown
on
May 01, 2025
Rating:
No comments: